Cell adhesion molecules as targets for therapy of neuroblastoma

Cancer Biology and Therapy

Volumn 8, Issue 4, 2009, Pages 306-311

  Yoon, Karina Jin ^a   Danks, Mary K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Actin; Cadherins; CD44; Cytoskeleton; Metastasis; NCAM; Neuroblastoma; Selectins

Indexed keywords

ACTIN; CADHERIN; CELL ADHESION MOLECULE; HERMES ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 2; NERVE CELL ADHESION MOLECULE; SELECTIN;

COLON CANCER; CYTOSKELETON; HUMAN; METASTASIS; MOLECULAR INTERACTION; NEUROBLASTOMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW;

EID: 62549160002     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.4.7446     Document Type: Review

References (68)

1. Gumbiner BM. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996; 84:345-57.
2. Takeichi M. Cadherins: A molecular family important in selective cell-cell adhesion. Ann Rev Biochem 1990; 59:237-52.
3. Springer TA. Traffic signals for lymphocyte regulation and leukocyte emigration: The multiple paradigm. Cell 1994; 76:301-14.
4. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-101.
5. Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24:249-57.
6. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999; 17:2264-79.
7. Aronson MR, Smoker WRK, Oetting GM. Hemorrhagic intracranial parenchymal metastasis from primary retroperitoneal neuroblastoma. Pediatric Radiol 1995; 25:284-5.
8. Ara T, DeClerck YA. Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 2006; 25:645-57.
9. Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critica step in metastasis: In vivo analysis of intravasation at the primary tumor. Cancer Res 2000; 60:2504-11.
10. Favrot MC, Combaret V, Goillot E, Lutz P, Frappaz D, Thiesse P, et al. Expression of integrin receptors on 45 clinical beuroblastoma specimens. Int J Cancer 1991; 49:347-55.
11. Meyer A, van Golen CM, Kim B, can Golen KL, Feldman EL. Integrin expression regulates neurobastoma attachement and migration. Neoplasia 2004; 6:332-42.
12. Judware R, Cupl LA. Comcominant downregulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1. Oncogene 1997; 14:1341-50.
13. Gladson CL, Hancock S, Arnold MM, Faye-Peterson OM, Castleberry RP, Kelly DR, et al. Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors. Am J Pathol 1996; 148:1423-34.
14. Tanaka N, Fukuzawa M. MYCN downregulates integrin a1 to promote invasion of human neuroblastoma cells. Int J Oncol 2008; 33:815-21.
15. Rozzo C, Ratti P, Ponzoni M, Cornaglia-Ferraris P. Modulation of alpha1beta1, alpha2beta1 and alpha3beta1 integrin heterodimers during human neuroblastoma cell differentiation. FEBS Lett 1993; 332:263-7.
16. van Golen CM, Soules ME, Grauman AR, Feldman EL. N-myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells. Oncogene 2003; 22:2664-73.
17. Takeichi M. Cadherin cell adhesion receptors as a morphogetic regulator. Science 1991; 251:1451-5.
18. Cavallaro U, Christofori G. Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4:118-32.
19. Shimono R, Matsubara S, Takamatsu H, Fukushige T, Ozawa M. The expression of cadherin in human neuroblastoma cell lines and clinical tumors. Anticancer Res 2000; 20:917-23.
20. Barthel SR, Gavino JD, Descheny L, Dinitroff CJ. Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 2007; 11:1473-91.
21. Stone JP, Wagner DD. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 1993; 92:804-13.
22. Skotheim RI, Nees M. Alternative splicing in cancer: Noise, functional or systematic? Int J Biochem Cell Biol 2007; 39:1432-49.
23. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, et al. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicantric analysis of 121 pediatric neuroblastoma. J Clin Oncol1996; 14:25-34.
24. Terpe HJ, Christiansen H, Gonzalez M, Berthold F, Lampert F. Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 1995; 31:549-52.
25. Combaret V, Gross N, Lasset C, Frappaz D, Peruisseau G, Philip T, et al. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicantric analysis of 121 pediatric neuroblastoma. J Clin Oncol 1996; 14:25-34.
26. Comito MA, Savell VH, Cohen MB. CD44 expression in neuroblastoma and related tumors. J Ped Hematol 1997; 19:292-6.
27. Shtivelman E, Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 1991; 11:5446-53.
28. Munchar MJ, Sharifah NA, Jamal R, Looi LM. CD44s expression correlated with the international neuroblastoma pathology classification (Shimada system) for neuroblastoma tumours. Pathology 2003; 35:125-9.
29. Benard J. Genetic alterations associated with metastatic dissemination and chemoresistance in neuroblastoma. Eur J Cancer 1995; 31:560-4.
30. Favrot MC, Combaret V, Lasset C. CD44: A new prognostic marker for neuroblastoma. N Engl J Med 1993; 329:1965.
31. Sainio M, Zhao F, Heiska L, Turunen O, den Bakker M, Zwarthoff E, et al. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actincontaining cytoskeleton. J Cell Sci 1997; 110:2249-60.
32. Kahsai AW, Zhu S, Wardrop DJ, Lane WS, Fenteany G. Quinocarmycin analog DX-52-1 inhibits cell migration and targets radixin, disrupting interactions of radixin with actin and CD44. Chem Biol 2006; 13:973-83.
33. Jensen PV, Larsson LI. Actin microdomains on endothelial cells: Association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing. Histochem Cell Biol 2004; 121:361-9.
34. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S, et al. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994; 126:391-401.
35. Weeds A. Actin-binding proteins-regulators of cell architecture and motility. Nature 1982; 296:811-6.
36. Pantaloni D, Le Clainche C, Carlier M-F. Mechanism of actin-based motility. Science 2001; 292:1502-6.
37. Bourne SP, Patel K, Walsh F, Popham CJ, Coakham HB, et al. A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm. I Neurooncol 1991; 10:111-9.
38. Yang P, Major D, Routishauser U. Role of charge and hydration in effects of polysialic acid on molecular interactions on and between cell membranes. J Biol Chem 1994; 269:23039-44.
39. Blaheta RA, Hundemer M, Mayer G, Vogel JU, Kornhuber B, Cinatl J, et al. Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro. Cell Commun Adhes 2002; 9:131-47.
40. Cervello M, D'Amelio L, Tesoro V, Rougon G, Matranga V. Expression of PSA-N-CAM In human neuroblastoma cells induced to neuronal differentiation by retinoic acid. Eur J Cell Biol 1997; 73:270-5.
41. Winter C, Bruce P, Seiser E, Huaqing Z, Raabe E, Wang Q, et al. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Pediatr Blood Cancer 2008; 51:10-6.
42. Gluer S, Schelp C, Gerardy-Schahn R, von Schweinitz D. Polysialylated neural cell adhesion molecule as a marker for differential diagnosis in pediatric tumors. J Pediatr Surg 1998; 33:1516-20.
43. Gluer S, Schelp C, Mardy N, von Schweinitz D, Eckhardt M, Gerardy-Schahn R, et al. Serum polysialylated neural cell adhesion molecule in childhood neuroblastoma. Br J Cancer 1998; 78:106-10.
44. Fearson ER, Cho KR, Nigro JM, Kern SE, Simons JW, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247:49-56.
45. Lawlor K, Narayanan R. Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth Differ 1992; 3:609-16.
46. Kong XT, Choi SH, Inoue A, Xu F, Chen T, Takita J, et al. Expression and mutation analysis of the DCC, DPC4 and MADR2/JV18-1 genes in neuroblastoma. Cancer Res 1997; 57:3772-8.
47. Reale MA, Reyes-Mugiva M, Pierceall WE, Rubinstein MC, Hedrick L, Cohn SL, et al. Loss of DCC expression in neuroblastoma is associated with disease dissemination. Clin Cancer Res 1996; 2:1097-102.
48. Reyes-Mugica M, Lin P, Yokota J, Reale MA. Status of deleted in colorectal cancer gene expression correlates with neuroblastoma metastasis. Lab Invest 1998; 78:669-75.
49. Reale MA, Hu G, Getzenberg RH, Zafar AI, Levine SM, Fearon ER, et al. Expression of the deleted in colon cancer (DCC) tumor suppressor gene in cell lines and normal and malignant tissues: Evidence for alternative splicing. Cancer Res 1994; 54:4493-501.
50. Carpenito C, Pyszniak AM, Takei F. ICAM-2 provides a costimulatory signal for T cell stimulation by allogeneic Class II MHC. Scand J Immunol 1997; 45:248-54.
51. Tanaka H, Yashiro M, Sunami T, Sakate Y, Kosaka K, Hirakawa K, et al. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 2004; 10:4885-92.
52. deFougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174:253-67.
53. Kotovuori A, Pessa-Morikawa T, Kotovuori P, Nortamo P, Gahmberg CG. ICAM-2 and a peptide from its binding domain are efficient activators of leukocyte adhesion and integrin affinity. J Immunol 1999; 162:6613-20.
54. Reiss Y, Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: transendothelial migration of different T cell populations is mediated by endothelial ICAM-1 and ICAM-2. Int Immunol 1999; 11:1527-39.
55. Issekutz AC, Rowter D, Springer TA. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J of Leukocyte Biol 1999; 65:117-26.
56. Diacovo TG, deFourgerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: Intercellular adhesion molecule-2. J Clin Invest 1994; 94:1243-51.
57. Perez OD, Kinoshita S, Hitoshi Y, Payan DG, Kitamura T, Nolan GP, et al. Activation of the PKB/AKT pathway by ICAM-2. Immunity 2002; 16:51-65.
58. Huang M-T, Mason JC, Birdsey GM, Amsellem V, Gerwin N, Haskard DO, et al. Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood 2005; 106:1636-43.
59. Yoon KJ, Phelps DA, Burger RA, Remack JS, Billups C, Khoury JD, et al. ICAM-2 mediates a membrane-to-actin linkage, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma. PLoS ONE 2008; 3:3629.
60. Bretscher A. Regulation of cortical structure by the ezrin-radixin-moesin protein family. Curr Opin Cell Biol 1999; 11:109-16.
61. Sun C-X, Robb VA, Gutmann DH. Protein 4.1 tumor suppressors: Getting a FERM grip on growth regulation. J Cell Sci 2002; 1153400-991.
62. Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005; 96:379-86.
63. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, et al. Actinin-4, a novel actinbundling proteinm associated with cell mobility and cancer invasion. J Cell Biol 1998; 140:1383-93.
64. Ridly AJ, Schwatz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: Integrating signals from front to back. Science 2003; 302:1704-9.
65. Pollard TD, Borisy GG. Cellular motility driven by assembly and dissembly of actin filaments. Cell 2003; 112:453-65.
66. Hunter KW. Ezrin, a key component in tumor metastasis. Trends Mol Med 2004; 201-4.
67. Nikolopoulos SN, Spengler BA, Kisselbach K, Evans AE, et al. The human non-muscle α-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 2000; 19:380-6.
68. Comoglio PM, Boccaccio C, Trusolino L. Interactions between growth factor receptors and adhesion molecules: Breaking the rules. Curr Opin Cell Biol 2003; 15:565-71.